TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Craig Hockenberry’s Oct. 28, 2026, post recounts his experience with lymphoma treatment, including chemotherapy, a serious bout of pneumonia and nerve damage that later showed signs of improvement. The supplied report ends mid-sentence and does not state his current diagnosis, treatment status or prognosis.
Craig Hockenberry published a personal health update on Oct. 28 describing treatment for lymphoma, including chemotherapy, a bout of pneumonia and a later return of sensation that he interpreted as a possible sign of nerve recovery. His account documents the effects treatment had on his mobility, weight and daily life, but the supplied report ends before explaining what caused the change in his symptoms or stating his current medical status.
Hockenberry said his treatment began with a six-week course of lumbar punctures, which ended in late January. During the procedures, he wrote, doctors removed and replaced spinal fluid with methotrexate. He described severe headaches afterward and said lying flat eased them. He later received infusions of bendamustine and rituximab on a 28-day cycle.
He reported changes in taste, fatigue and loss of muscle mass, as well as losing 50 pounds over a couple of months. He said he did not experience nausea or hair loss, though his hair lost its usual body. He described taking daily walks with walking sticks despite weakness and existing nerve damage, and said his walking gradually increased as he recovered after his final infusion in May.
In March, according to his account, he developed a type of pneumonia affecting people with weakened immune systems. He said his blood oxygen level fell below 90% and his Apple Watch registered an episode of atrial fibrillation. He wrote that antibiotics treated the pneumonia and that his doctor offered to skip the next chemotherapy cycle; Hockenberry said he chose to continue. He later described a new sensation in the backs of his legs after a walk, which he took as a possible sign that spinal nerves were recovering.
Treatment Effects and Daily Function
Hockenberry’s account offers a first-person description of how cancer treatment affected mobility, appetite, weight and stamina over several months. It also records a serious infection during chemotherapy and symptoms that he associated with atrial fibrillation, illustrating the health challenges he says occurred alongside his lymphoma treatment.
The account is not a clinical report and does not establish how common these effects are or what caused each symptom. Its significance for readers lies in the specific experience he shares, rather than in evidence that another patient will have the same course. Treatment decisions and responses vary; people undergoing chemotherapy should discuss symptoms or changes with their care team.
Products Worth Considering
Bowflex SelectTech 840 Adjustable Kettlebell
BowFlex Results Series SelectTech Adjustable Dumbbells, Pair
Withings BPM Connect Smart Blood Pressure Monitor
As an affiliate, we earn on qualifying purchases.
A Timeline From January to May
Hockenberry’s post, published by Furbo.org, is written in the first person and describes events over the preceding months. He said the lumbar punctures concluded at the end of January, followed by chemotherapy infusions on a 28-day schedule. He placed his lowest point in March, when he reported pneumonia, low blood oxygen and an alert for atrial fibrillation.
He said he completed his final infusions in May and then gradually regained strength and stamina. His account says the nerve symptoms had persisted during treatment, including numbness and tingling and difficulty with balance and stairs. The later leg sensation occurred during a walk after his recovery had begun. The source text provided here breaks off before completing Hockenberry’s explanation of what might have contributed to that change.
““Everyone experiences chemotherapy differently.””
— Craig Hockenberry
Current Health Status Not Stated
The supplied report does not say whether Hockenberry remains in treatment, whether tests confirmed the lymphoma’s response, or what his current prognosis is. It also does not identify the type of lymphoma or provide details of his care beyond the procedures and drugs he named.
Hockenberry said he and others had a theory about why the sensation in his legs changed, but the source text cuts off before that explanation is complete. No medical evaluation or test result confirming nerve repair is included. His reported atrial fibrillation alert is not accompanied by information about a diagnosis or follow-up.
Further Medical Details Await
The post establishes no upcoming treatment date, planned test or follow-up milestone. Any update on Hockenberry’s diagnosis, lymphoma response, nerve symptoms or recovery would need to come from him or an attributed medical source. Until then, the account supports only a description of treatment through May and the improvement he said he noticed afterward.
Readers should treat the narrative as an individual account, not as medical guidance. Anyone experiencing breathing problems, a major drop in oxygen readings, new heart symptoms or worsening neurological signs during treatment should contact a clinician or seek urgent care as appropriate.
Key Questions
Who published the health update?
Craig Hockenberry published the personal account on Furbo.org on Oct. 28, 2026.
What chemotherapy did Hockenberry describe?
He said he received infusions of bendamustine and rituximab on a 28-day cycle. He also described an earlier six-week course of lumbar punctures involving methotrexate.
What health problems did he report during treatment?
He described fatigue, changes in taste, muscle loss, substantial weight loss and ongoing nerve symptoms. He also said he developed pneumonia in March, with blood oxygen below 90%, and that his Apple Watch registered an atrial fibrillation episode.
Did Hockenberry say his nerve damage had recovered?
No confirmed recovery is reported. He described a new sensation in his legs that he interpreted as a possible sign of nerve repair, but the supplied post ends before explaining his theory or providing medical confirmation.
Is his current treatment or prognosis known?
The supplied account does not state his current treatment status, lymphoma response or prognosis. It says he completed his final infusions in May and gradually began to regain strength, but provides no later clinical update.
Source: furbo.org
